Tag: NeuroRx Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to NeuroRx Inc.

NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI™ (RLF-100™: aviptadil ...

Added to Collection on: 2021-01-11 06:00:00

Tags for this article:

Agencies of the United States government
SEC filings
Initial public offering
Prospectus
Forward-looking statement
Proxy statement
United States Securities Regulation
U.S. Securities and Exchange Commission
Stock market
Aviptadil
Food and Drug Administration
Companies
Jonathan C. Javitt
RELIEF THERAPEUTICS Holding AG
NASDAQ COMPOSITE INDEX
NeuroRx Inc.

Click the tags to see associated articles and topics

View Article Details
NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI ...

Added to Collection on: 2021-02-09 13:07:30

Tags for this article:

Respiratory diseases
Medical specialties
Medicine
SEC filings
Acute respiratory distress syndrome
Intensive care medicine
Respiratory physiology
Coronavirus disease
Proxy statement
Severe acute respiratory syndrome
Forward-looking statement
COVID-19 drug repurposing research
Jonathan C. Javitt
Relief Therapeutics Holdings AG
NeuroRx Inc.

Click the tags to see associated articles and topics

View Article Details
NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for ...

Added to Collection on: 2021-03-26 13:41:15

Tags for this article:

U.S. Securities and Exchange Commission
73rd United States Congress
Agencies of the United States government
Financial markets
SEC filings
Shareholders
Corporate governance
Initial public offering
Prospectus
Securities Act
Proxy statement
Securities Exchange Act
NeuroRx Inc.

Click the tags to see associated articles and topics

View Article Details
NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 ...

Added to Collection on: 2021-03-29 05:03:45

Tags for this article:

Medical specialties
Medicine
Health
Intensive care medicine
Relief Therapeutics
Cycloserine/lurasidone
Aviptadil
Acute respiratory distress syndrome
COVID-19
Angiotensin-converting enzyme 2
Placebo
Mechanical ventilation
RELIEF THERAPEUTICS Holding AG
United States
NeuroRx Inc.

Click the tags to see associated articles and topics

View Article Details
NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored ...

Added to Collection on: 2021-04-06 04:52:30

Tags for this article:

U.S. Securities and Exchange Commission
73rd United States Congress
Agencies of the United States government
Financial markets
SEC filings
Shareholders
Corporate governance
Initial public offering
Prospectus
Securities Act
Proxy statement
Cycloserine/lurasidone
NeuroRx Inc.
Aviptadil

Click the tags to see associated articles and topics

View Article Details
(PRNewsfoto/NeuroRx)

Added to Collection on: 2021-04-06 04:52:30

Tags for this article:

Life Sciences
Health care
Health sciences
Antiviral drugs
Orphan drugs
COVID-19 drug development
Nucleotides
Remdesivir
Relief Therapeutics
Aviptadil
Gilead Sciences
National Institutes of Health
NeuroRx Inc.
RELIEF THERAPEUTICS Holding AG

Click the tags to see associated articles and topics

View Article Details